Post-Patent Expiry Boom, Empagliflozin Sees Brand Flood, 147 Brands Launched: Pharmatrac Farhat Nasim9 May 2025 7:51 PM ISTEmpagliflozin plain and its combination with Linagliptin currently account for about 80% of total sales in this Rs 745 crore market.
NPPA fixes ceiling prices for 84 drug formulations; focus on Empagliflozin-based Diabetes therapies Ruchika Sharma8 May 2025 2:14 PM ISTNew Delhi: In a fresh directive aimed at curbing treatment costs and improving access to essential medicines, the National Pharmaceutical Pricing...
Dettol Controversy: Reckitt Settles with Influencer Raj Shamani, But To Proceed Legally Against Dermatologist Farhat Nasim7 May 2025 7:41 PM ISTNew Delhi: Reckitt Benckiser, the company behind Dettol, has informed the Delhi High Court that it has reached a settlement with popular social media...
Ranitidine Under Scanner Again: DTAB, CDSCO Recommend New Safety Study, Tighter Monitoring Farhat Nasim6 May 2025 6:02 PM ISTNew Delhi: Amid continued global concerns over the presence of N-nitrosodimethylamine (NDMA) impurities in ranitidine, the Drugs Technical Advisory...
Substandard Drugs to Face Immediate License Suspension Under DTAB's New Recommendation Farhat Nasim5 May 2025 5:16 PM ISTNew Delhi: In a significant move to tighten quality control and safeguard public health, the Drugs Technical Advisory Board (DTAB) has recommended...
Batch of Tofajak Tablets earlier classified as NSQ now flagged as Spurious Dr. Divya Colin4 May 2025 6:00 PM ISTNew Delhi: Through a recent revised drug alert, the Central Drugs Standard Control Organization (CDSCO) has classified a batch of Tofacitinib Tablets...
Not a Nice Time For Nimesulide? DTAB, CDSCO Recommend Stringent Restrictions Farhat Nasim3 May 2025 7:31 PM ISTNew Delhi: Nimesulide, a widely used painkiller in India, is facing renewed regulatory scrutiny over its safety profile, with India's apex drug...
MSN Laboratories Gets CDSCO Panel Nod To study Brexpiprazole Tablets Dr. Divya Colin2 May 2025 6:00 PM ISTNew Delhi: Considering the bioequivalence study of Brexpiprazole Tablets 0.25mg /0.5 mg/1mg/2mg/3mg/4mg, the Subject Expert Committee (SEC) functional...
'Ghatiya' Is Hyperbole, Not Defamation: HC Declines to Restrain Influencers' Criticism of Protein Supplement Farhat Nasim1 May 2025 7:41 PM ISTNew Delhi: In a significant ruling defining the boundaries of free speech and online criticism in the digital age, the Delhi High Court has refused to...
Revise study protocol: CDSCO Panels tells Lupin on Ranibizumab Solution for Injection 10 mg/mL Dr. Divya Colin30 April 2025 6:00 PM ISTNew Delhi: Responding to the drug major Lupin's proposal to conduct phase IV clinical trial of the ophthalmic drug Ranibizumab Solution for Injection...
61 Formulations declared Not of standard quality as per data provided by states: CDSCO Drug Alert Dr. Divya Colin29 April 2025 6:00 PM ISTNew Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central Drug Standard Control...
Minor Drug Law Violations Can Now Be Settled Without Trial: Health Ministry Issues Rules Farhat Nasim28 April 2025 7:21 PM ISTNew Delhi: The Ministry of Health and Family Welfare has notified the Drugs and Cosmetics (Compounding of Offences) Rules, 2025, allowing...
